Atlas Trials

Study to Investigate the Effect of Paroxetine Mediated CYP2D6 Inhibition on the Pharmacokinetics of Tamsulosin in Healthy Male Volunteers

Clinical trial NCT02264184 · COMPLETED

Trial details

NCT number
NCT02264184
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2008-09-01
Primary completion
2008-12-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.